The present study showed that TGFβ signaling in cancer cells induced by intrinsic PD-L1 function can contribute to EMT and immune evasion of cancer, compromising the responsiveness to ICI therapy (Supplementary Fig. S12). This evidence concerns the gene TGFB1 and cancer.